Overall Technical outlook

Price Summary

WST's shares experienced a significant -3.24% fall, indicating a poor market performance.
On 2026-04-28, West Pharmaceutical Services, Inc.'s stock opened at 301.91, spiked to 302.55, declined to 290.41, and closed -3.24% lower at 292.13, with 1042482 shares traded.
Over the course of 52 weeks, the stock peaked at 309.7 and hit a low of 205.36.
Analysts' predictions indicate that WST's future price will be between 275.0 and 390.0, with a mean price expectation of approximately 324.33334.

Technicals


Aroon: The AROON is in a neutral stance for WST, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
WST aroon 71523e
Aroon chart for West Pharmaceutical Services, Inc.


Bol. Bands: The current reading of the BOLL BANDS is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
WST bbands 71523e
Bolinger Bands chart for West Pharmaceutical Services, Inc.


Parabolic SAR: The PSAR remains bullish in its outlook, establishing a key support level that could serve as a foundation for further upward movement. This persistent bullish stance suggests that the market may continue to trend higher, with the established support providing a potential safety net for investors.
WST psar 71523e
Parabolic Stop and Reverse chart for West Pharmaceutical Services, Inc.


Stochastic: The STOCHASTIC is showing a neutral stance, with no definitive indication of an upward or downward trend for WST. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
WST stoch 71523e
Stochastic chart for West Pharmaceutical Services, Inc.


Tripple Moving Agerage: The Tripple MOVING AVG is currently neutral, offering no clear guidance on market direction. This suggests that the market may be in a state of pause, with no strong trend emerging.
WST trippleSMA 71523e
Tripple SMA chart for West Pharmaceutical Services, Inc.


Before focusing on technical indicators like stock price and volume, it's important to consider a company's fundamentals. These include financial metrics such as profitability, revenue growth, and debt levels. Furthermore, understanding the industry landscape, including competition and consumer trends, provides essential context. By combining this fundamental analysis with technical data, investors can make more informed decisions and draw deeper conclusions about the company's potential for future growth and success.